Visual epilepsy

Related records

Broader conditions (13)

• Brain disorder
• Central nervous system disorder
• Cerebral cortex disorder
• Disease
• Disease by body system or component
• Disorder of visual system
• Epilepsy
• Human disease
• Nervous system disorder
• Reflex epilepsy
• Vision disorder
• Visual cortex disorder
• Visual pathway disorder

Narrower conditions (2)

• Microcephaly micropenis convulsions
• Microcephaly sparse hair intellectual disability seizures

Trials (888)

• 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
• 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures
• 8-OHdG and Oxidative Stress in Febrile Seizures
• A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
• A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome
• A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
• A Biosensor for Tracking Seizures: Linking a Wrist Accelerometer to an Online Epilepsy Diary
• A Clinical Decision Aid for Diagnosing Transient Loss of Consciousness
• A Clinical Study of Children With Status Epilepticus in China
• A Clinical Study of Epilepsy Localization and Prognosis Based on PET and Resting-state fMRI
• A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994
• A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
• A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
• A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment
• A Controlled Clinical Trial of Cathodal Transcranial Direct Current Stimulation in Patients With Refractory Epilepsy
• A Cross-Sectional Study of Serum Levels of Adipocytokines in Children With Febrile Seizures
• A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy
• A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
• A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)
• A Long Term Extension Study of E2080 in Lennox-Gastaut Patients

Approved drugs (33)

• Acetazolamide
• Acetazolamide sodium
• Brivaracetam
• Cannabidiol
• Carbamazepine
• Cenobamate
• Clobazam
• Clonazepam
• Clorazepate dipotassium
• Divalproex sodium
• Eslicarbazepine acetate
• Ethotoin
• Ezogabine
• Felbamate
• Gabapentin
• Ganaxolone
• Lacosamide
• Lamotrigine
• Levetiracetam
• Magnesium sulfate

Drugs in development (16)

• Alprazolam Phase 3
• Azetukalner Phase 3
• Bumetanide Phase 1
• Cannabinol Phase 2
• Carisbamate Phase 3
• Darigabat Phase 2
• Diazepam Phase 3
• Doxycycline Phase 2
• Ethosuximide Phase 3
• JNJ-40411813 Phase 2
• Lorazepam Phase 2
• Midazolam Phase 2
• Phenobarbital Phase 1
• Selurampanel Phase 2
• Valproate sodium Phase 1
• Zandatrigine Phase 1